INTERNATIONAL PATENT: ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY, 复旦大学附属中山医院 FILES APPLICATION FOR "TPK EXPRESSION VIRUS CAPABLE OF BEING ADMINISTERED THROUGH INTRAVENOUS INJECTION AND USE THEREOF IN TREATING ALZHEIMER'S DISEASE"

GENEVA, March 16 -- ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY (136 Yixueyuan RoadXuhui District, Shanghai 200032), 复旦大学附属中山医院 (中国上海市徐汇区医学院路136号) filed a patent application (PCT/CN2024/102175) for "TPK EXPRESSION VIRUS CAPABLE OF BEING ADMINISTERED THROUGH INTRAVENOUS INJECTION AND USE THEREOF IN TREATING ALZHEIMER'S DISEASE" on Jun 28, 2024. With publication no. WO/2025/050785, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World...